Consistently, TLR2 knock-down (TLR2−/−) mice showed enhanced inflammation, hepatic lesions and HCC progression after carcinogenic diethylnitrosamine exposure [9, 39]. Here, TLR2 is linked to hepatocellular carcinoma.